Automated Reminders for Colorectal Cancer Screening

Not currently recruiting at 3 trial locations
TC
AN
Overseen ByAnnella Nelson
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Louisiana State University Health Sciences Center Shreveport
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores ways to help people maintain their colorectal cancer screening routines, especially in rural areas with limited resources. It compares two approaches: one provides educational materials only, while the other includes automated call or text reminders about screenings. Individuals who have visited a participating health clinic in the past year, speak English, and are not up-to-date with their colorectal cancer screenings may be suitable for this study. As an unphased trial, it offers a unique opportunity to contribute to improving cancer screening adherence in underserved communities.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. It seems unlikely that you would need to stop, as the trial focuses on reminders for colorectal cancer screening.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on promoting colorectal cancer screening and does not mention medication changes.

What prior data suggests that these automated reminders are safe for promoting CRC screening?

Research shows that automated call or text reminders safely help people remember to complete colorectal cancer screenings. Although specific safety data for these reminders is lacking, they are widely used in healthcare. These reminders function like appointment notifications via text or call.

Studies have found that reminders, such as phone calls and letters, are common in healthcare and usually don't cause harm. Automated reminders serve as another tool to help people maintain their health routines. While live phone calls can sometimes be more effective, automated texts and calls remain helpful and safe.

No reports of negative side effects have emerged from using automated reminders for health screenings, suggesting that people generally handle them well. Prospective participants in studies using these reminders can feel confident in their safety, based on their current use in healthcare.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores new ways to boost colorectal cancer (CRC) screening rates. Unlike traditional approaches that rely on patients remembering to schedule and attend screenings on their own, this trial uses automated reminders via calls and texts to nudge patients toward getting screened. By incorporating health literacy-appropriate educational materials and shared decision-making into the process, this approach aims to make the screening process easier and more accessible. This could lead to increased screening rates and earlier detection of CRC, potentially improving outcomes for many patients.

What evidence suggests that this trial's treatments could be effective for colorectal cancer screening?

Research has shown that automated calls and texts can increase participation in colorectal cancer screening. In this trial, participants in the PRIME CRC arm will receive these automated reminders to encourage screening. These reminders keep the screening on patients' minds, leading to higher screening rates. For example, automated calls are especially effective for older patients. Text message reminders also boost participation, though they might not be as effective if used alone. Overall, these strategies encourage more people to complete their screening tests, which is important for early detection of colorectal cancer.26789

Who Is on the Research Team?

CL

Connie L Arnold, PhD

Principal Investigator

LSU Health Sciences Center Shreveport

Are You a Good Fit for This Trial?

The PRIME-CRC Trial is for English-speaking individuals aged 45 to 75 who have visited participating rural health clinics in the past year. It's not for those up-to-date with CRC screening, very ill patients, or those with cognitive impairments, significant hearing or vision issues, a family history requiring different screening due to risk factors, or a history of cancer other than non-melanoma skin cancer.

Inclusion Criteria

English-speaking
Have been a patient at one of the participating FQHCs with at least one prior visit in the past 12 months
I am between 45 and 75 years old.

Exclusion Criteria

Have a documented or uncorrectable cognitive, hearing, or visual impairment
Are up-to-date with CRC screening according to USPSTF guidelines (FOBT in less than a year, sigmoidoscopy less than 5 years, or colonoscopy less than 10 years)
I am too sick to take part in the study.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive patient-centered reminders and health literacy education to promote CRC screening adherence via colonoscopy or annual FIT

3 years
Frequent follow-up contact via automated call or SMS text

Follow-up

Participants are monitored for completion of CRC screening and adherence to screening guidelines

3 years

What Are the Treatments Tested in This Trial?

Interventions

  • automated call reminders or automated texts
  • health literacy appropriate education and demonstration
  • shared decision making
Trial Overview This trial tests an educational program designed to help people in rural areas stick with colorectal cancer (CRC) screenings over time. One group gets enhanced usual care; the other also receives automated calls or texts as reminders about test preparations and follow-ups.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Enhanced Usual CareActive Control2 Interventions
Group II: PRIME CRCActive Control3 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Louisiana State University Health Sciences Center Shreveport

Lead Sponsor

Trials
52
Recruited
19,400+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Northwestern University

Collaborator

Trials
1,674
Recruited
989,000+

Published Research Related to This Trial

Low-literacy, wordless instructions for completing the fecal immunochemical test (FIT) were developed and tested, showing a preference among Spanish-speaking patients over traditional lengthy instructions.
The study suggests that these simplified instructions could improve colorectal cancer screening rates in low-literacy and non-English-speaking populations, highlighting the importance of accessible health communication.
Advantages of wordless instructions on how to complete a fecal immunochemical test: lessons from patient advisory council members of a federally qualified health center.Coronado, GD., Sanchez, J., Petrik, A., et al.[2021]
In a study involving 263 participants aged 50-74, over half had limited health literacy, yet most were able to complete computer-based educational programs on colorectal cancer screening without assistance, indicating the potential of such tools for patient education.
Participants reported learning more from the computer programs than from traditional brochures, suggesting that computer-assisted instruction could effectively enhance understanding, especially for those with varying literacy levels.
Health literacy and computer-assisted instruction: usability and patient preference.Duren-Winfield, V., Onsomu, EO., Case, DL., et al.[2018]
Most web-based patient education materials on colorectal cancer screening are written at a reading level above the recommended sixth-grade level, making them difficult for many patients to understand.
The materials often lack important health content, such as addressing specific risks for high-risk groups and common barriers to screening, which could hinder patient engagement and screening rates.
Readability, suitability, and health content assessment of web-based patient education materials on colorectal cancer screening.Tian, C., Champlin, S., Mackert, M., et al.[2022]

Citations

Randomized Controlled Trial of Advance Notification ...Our previous research has shown text messages perform worse than other modes when delivered as reminders to mailed FIT outreach. In contrast, advance ...
Effectiveness of automated and live phone reminders after ...Moreover, an auto-call was more effective among older than younger patients (Mosen et al., 2010). In a study of phone-delivered colorectal cancer screening ...
Effectiveness and Acceptability of Targeted Text Message ...Background: Mobile phone–based SMS text message reminders have the potential to improve colorectal cancer screening participation rates.
Randomized Controlled Trial (M-TICS Study)Mobile phone–based SMS text message reminders have the potential to improve colorectal cancer screening participation rates.
Text-message Reminders in Colorectal Cancer Screening ...We investigated the effectiveness of a text-message reminder to improve uptake of the English Bowel Cancer Screening programme in London.
Automated Reminders for Colorectal Cancer ScreeningIs it safe to use automated reminders for colorectal cancer screening? There is no specific safety data available for automated reminders like calls or texts ...
Live Phone Calls Better Than Text Messages to Remind ...Live phone calls significantly outperform text messages and letters as a way to remind patients to complete and return at-home screening tests for colon cancer.
Repeated Automated Mobile Text Messaging Reminders for ...Objective: The objective of this study was to examine the effectiveness of text messaging (short message service, SMS) in increasing adherence ...
Using text message reminders in health care servicesMulti-component reminders to complete colorectal cancer screening including automated text messages, mailed letters, and phone calls among a high cancer ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security